Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alteplase vs Streptokinase in Mechanical Prosthetic Valve Thrombosis
NCT07360717Completed
- Sponsor
- U. N. Mehta Institute of Cardiology and Research Center
- Start
- Nov 2024
- Primary completion
- Dec 2025
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Randomised, open-label trial of tissue-plasminogen activator in prosthetic valve thrombosis (PVT) (2 arms), sponsored by U. N. Mehta Institute of Cardiology and Research Center. Primary endpoints: Complication Rates (minor + non-fatal major + fatal) at 30 days and Success Rate of Thrombolysis. Started Nov 2024; status: completed.
02
Drugs
tissue-plasminogen activator
03
Conditions
prosthetic valve thrombosis (PVT)
Beyond the preview
Go deeper on NCT07360717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07360717.